



Cagrilintide CAS 1415456-99-3 with COA
Research tool for obesity mechanisms and combination therapy development.
Pharmaceutical candidate for metabolic disorders, including type 2 diabetes and obesity-related comorbidities.
Контакти
Потребител
Форма за контакт
Cagrilintide CAS 1415456-99-3 with COA 0 reviews
Write Your ReviewThere are no reviews yet.
Подобни обяви

Популярна
Нова
CAS 1451-82-7
0.0- май 6, 2025
11

Популярна
Нова
CAS 1451-82-7
0.0- май 6, 2025
11